tiprankstipranks
Virios Therapeutics, Wex Pharmaceuticals announce 25-for-1 reverse stock split
PremiumThe FlyVirios Therapeutics, Wex Pharmaceuticals announce 25-for-1 reverse stock split
2M ago
Virios Therapeutics reports Q2 EPS (5c), consensus (6c)
Premium
The Fly
Virios Therapeutics reports Q2 EPS (5c), consensus (6c)
4M ago
Virios completes enrollment in IMC-2 Phase 2 Long COVID study
Premium
The Fly
Virios completes enrollment in IMC-2 Phase 2 Long COVID study
4M ago
Virios Therapeutics reports Q1 EPS (7c) vs. (8c) last year
PremiumThe FlyVirios Therapeutics reports Q1 EPS (7c) vs. (8c) last year
7M ago
Virios Therapeutics announces publication of international patent for IMC-2
Premium
The Fly
Virios Therapeutics announces publication of international patent for IMC-2
8M ago
Virios Therapeutics expects resources to fund operations into 4Q24
Premium
The Fly
Virios Therapeutics expects resources to fund operations into 4Q24
9M ago
Virios reaches alignment with FDA on requirements for IMC-2 advancement
PremiumThe FlyVirios reaches alignment with FDA on requirements for IMC-2 advancement
11M ago
Virios Therapeutics reports Q3 EPS (6c) vs. (28c) last year
Premium
The Fly
Virios Therapeutics reports Q3 EPS (6c) vs. (28c) last year
1y ago
VIRI Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
VIRI Earnings Report this Week: Is It a Buy, Ahead of Earnings?
1y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100